Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 20, 2022

SELL
$137.62 - $174.96 $104,178 - $132,444
-757 Reduced 11.24%
5,978 $915,000
Q1 2021

Jun 15, 2021

BUY
$102.3 - $112.62 $688,990 - $758,495
6,735 New
6,735 $728,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Applied Capital LLC Portfolio

Follow Applied Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Applied Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Applied Capital LLC with notifications on news.